Skip to main content

Advertisement

SpringerLink
Log in

Hepatic encephalopathy: you should only comment on what you have actually measured

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Senzolo M, Fung K, et al. TIPS for refractory ascites: a single-centre experience. J Gastroenterol. 2009;44:1089–95.

    Article  PubMed  Google Scholar 

  2. Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori FM, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005;42:674–9.

    Article  CAS  PubMed  Google Scholar 

  3. Masson S, Mardini HA, Rose JD, Record CO. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM. 2008;101:493–501.

    Article  CAS  PubMed  Google Scholar 

  4. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004;19:253–67.

    Article  PubMed  Google Scholar 

  5. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–21.

    Article  PubMed  Google Scholar 

  6. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72:573–83.

    CAS  PubMed  Google Scholar 

  7. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–73.

    Article  CAS  PubMed  Google Scholar 

  8. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629–35.

    Article  PubMed  Google Scholar 

  9. Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet. 1957;273:867–71.

    Article  CAS  PubMed  Google Scholar 

  10. Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol. 1999;110:1334–44.

    Article  CAS  PubMed  Google Scholar 

  11. Riggio O, Nicolao F, Angeloni S, Masini A, Salvatori F, Fanelli F, et al. Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft. Scand J Gastroenterol. 2003;38:570–2.

    Article  CAS  PubMed  Google Scholar 

  12. Deltenre P, Mathurin P, Dharancy S, Moreau R, Bulois P, Henrion J, et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int. 2005;25:349–56.

    Article  CAS  PubMed  Google Scholar 

  13. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995;23:123–8.

    Article  CAS  PubMed  Google Scholar 

  14. Tripathi D, Helmy A, Macbeth K, Balata S, Lui HF, Stanley AJ, et al. Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol. 2004;16:9–18.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None to declare.

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Padua, Via Giustiniani, 2, 35128, Padua, Italy

    Sara Montagnese, Sami Schiff, Angelo Gatta & Piero Amodio

  2. Department of Clinical Medicine II, Gastroenterology, La Sapienza University of Rome, Rome, Italy

    Oliviero Riggio

  3. The Centre for Hepatology, Department of Medicine, Royal Free Campus, University College London Medical School, London, UK

    Marsha Y. Morgan

Authors
  1. Sara Montagnese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sami Schiff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angelo Gatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliviero Riggio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marsha Y. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Piero Amodio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara Montagnese.

Additional information

An answer to this letter to the editor is available at doi: 10.1007/s00535-009-0172-1.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montagnese, S., Schiff, S., Gatta, A. et al. Hepatic encephalopathy: you should only comment on what you have actually measured. J Gastroenterol 45, 342–343 (2010). https://doi.org/10.1007/s00535-009-0171-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0171-2

Keywords

Search

Navigation